Patent · US Expired

Compositions and methods for identifying agents that quantitatively alter detectable extramitochondrial DNA:mitochondrial DNA ratios

US6218117A · kind A · utility

16Cited by
2References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 15, 1998
Grant dateApr 17, 2001
Priority date
Expiry dateJun 15, 2018

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/172
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Compositions and methods based on quantification of extramitochondrial DNA (exmtDNA) sequences are provided that are useful for detecting the presence of or risk for having a disease associated with altered mitochondrial function, and for identifying agents suitable for treating such diseases. The exmtDNA sequences have strong homology to authentic mitochondrial DNA (mtDNA) sequences.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.